Asher Bio Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include Gossamer Bio.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | |
Founding Date | Founding Date 2016 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations San Diego, US HQ Dublin 2, IE |
Employees | Employees 1123% decrease | Employees 11820% increase |
Valuation ($) | Valuation ($) 452 m | Valuation ($) 208 m |
Financial | ||
Revenue (est.) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) |
Net income | Net income ($74.4m) (FY, 2025) | Net income ($170.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 50m | Total funding raised $ 480m |
For sources of this data, please see the company profile
View Company Profiles
Gossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company